| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Changes in morphine-induced activation of cerebral Na+,K+-ATPase during morphine tolerance: Biochemical and behavioral consequences
|
Gonzalez, Luis G.
|
|
2012
|
83 |
11 |
p. 1572-1581
10 p.
|
article
|
| 2 |
Characterisation of Nav types endogenously expressed in human SH-SY5Y neuroblastoma cells
|
Vetter, Irina
|
|
2012
|
83 |
11 |
p. 1562-1571
10 p.
|
article
|
| 3 |
Covalent binding of cisplatin impairs the function of Na+/K+-ATPase by binding to its cytoplasmic part
|
Huličiak, Miroslav
|
|
2012
|
83 |
11 |
p. 1507-1513
7 p.
|
article
|
| 4 |
Dehydroepiandrosterone (DHEA) inhibits voltage-gated T-type calcium channels
|
Chevalier, M.
|
|
2012
|
83 |
11 |
p. 1530-1539
10 p.
|
article
|
| 5 |
Editorial Board
|
|
|
2012
|
83 |
11 |
p. iii-
1 p.
|
article
|
| 6 |
Kinetic stabilization of microtubule dynamics by indanocine perturbs EB1 localization, induces defects in cell polarity and inhibits migration of MDA-MB-231 cells
|
Kapoor, Sonia
|
|
2012
|
83 |
11 |
p. 1495-1506
12 p.
|
article
|
| 7 |
Minor structural modifications to alchemix influence mechanism of action and pharmacological activity
|
Abdallah, Qasem M.A.
|
|
2012
|
83 |
11 |
p. 1514-1522
9 p.
|
article
|
| 8 |
Novel fluorescent antagonist as a molecular probe in A3 adenosine receptor binding assays using flow cytometry
|
Kozma, Eszter
|
|
2012
|
83 |
11 |
p. 1552-1561
10 p.
|
article
|
| 9 |
Targeting the Apo2L/TRAIL system for the therapy of autoimmune diseases and cancer
|
Martinez-Lostao, Luis
|
|
2012
|
83 |
11 |
p. 1475-1483
9 p.
|
article
|
| 10 |
3-(4-(tert-Octyl)phenoxy)propane-1,2-diol suppresses inflammatory responses via inhibition of multiple kinases
|
Yu, Tao
|
|
2012
|
83 |
11 |
p. 1540-1551
12 p.
|
article
|
| 11 |
The inhibitory glutathione transferase M2-2 binding site is located in divergent region 3 of the cardiac ryanodine receptor
|
Liu, Dan
|
|
2012
|
83 |
11 |
p. 1523-1529
7 p.
|
article
|
| 12 |
The multifaceted exosome: Biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities
|
Pant, Saumya
|
|
2012
|
83 |
11 |
p. 1484-1494
11 p.
|
article
|
Journal description